The safety of the temozolomide in patients with malignant glioma.

Current drug safety

Volumn 1, Issue 2, 2006, Pages 205-222

  Dario, Alessandro ^a   Tomei, Giustino ^a  

^a UNIVERSITY OF INSUBRIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; DACARBAZINE; DRUG DERIVATIVE; TEMOZOLOMIDE;

ADULT; CHEMICALLY INDUCED DISORDER; CHILD; CLINICAL TRIAL; DRUG INTERACTION; GLIOMA; HEMATOLOGIC DISEASE; HUMAN; INFECTION; NAUSEA; REVIEW; VOMITING;

ADULT; ANTINEOPLASTIC AGENTS, ALKYLATING; CHILD; CLINICAL TRIALS AS TOPIC; DACARBAZINE; DRUG INTERACTIONS; GLIOMA; HEMATOLOGIC DISEASES; HUMANS; INFECTION; NAUSEA; VOMITING;

EID: 50649107792     PISSN: 15748863     EISSN: None     Source Type: Journal    
DOI: 10.2174/157488606776930535     Document Type: Review

References (75)